June 8, 2009 (Chicago, Illinois) – Detection of "long DNA" in the stool, when combined with fecal occult blood testing, detects colorectal cancers with a specificity of 90%. This approach is "among ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

Fecal immunochemical testing, which tests for human blood in a patient’s stool, is now available as a take-home test from Life Line Screening, according to a company news release. The test requires no ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

An estimated 52,500 Americans died last year from colon cancer, yet the disease is highly treatable if it's detected early. Primary care and prevention experts from the U.S. Preventive Services Task ...

Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study. Unlike ...

March marks the beginning of Colorectal Cancer Awareness Month. At-home stool tests can be an easier way to screen for colorectal cancer than a dreaded colonoscopy. As the rates of the cancer continue ...

A fecal lactoferrin test can detect intestinal inflammation. High lactoferrin levels in stool suggest that inflammation is present. This may indicate a bacterial infection or inflammatory bowel ...

Please provide your email address to receive an email when new articles are posted on . Compared with the original Cologuard test approved by the FDA in 2014, the company’s next-generation test uses ...

About The Study: In this nested case-control study, completing fecal immunochemical test was associated with a lower risk of overall death from colorectal cancer, particularly in the left colon, and ...

Regular stool tests already used in NHS care, combined with dietary information, could help identify people with inflammatory bowel disease (IBD) at higher risk of relapse, a major study appearing in ...